NCT06015802View on ClinicalTrials.gov

Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2029

Conditions
Pituitary AdenomaNeuroendocrine Tumors
Interventions
OTHER

diagnosed and treated reasonably according to the clinical guidelines and clinical pathways

The clinical data and biological specimens of the selected patients were collected, and the patients were diagnosed and treated reasonably according to the clinical guidelines and clinical pathways. The prognosis and outcome of the disease within 5 years after discharge were observed.

Trial Locations (1)

510080

RECRUITING

endocrinology department of the first affiliated hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER